FisherBroyles Strengthens Atlanta IP Practice with Key Hires from Womble Bond Dickinson

In a strategic move to bolster its intellectual property capabilities, FisherBroyles has announced the recruitment of an experienced duo from Womble Bond Dickinson. The Atlanta office of the firm will see the addition of IP specialists Christopher Vaughan and Stacy Claerbout, both of whom bring a wealth of experience and expertise in intellectual property law…

Read More

Consulting Firm Appeals Federal Ruling in Salesforce Patent Dispute, Seeking Case Reinstatement

A consulting company has petitioned the Federal Circuit to reverse a ruling by a Nevada federal judge that dismissed its lawsuit against Salesforce. The lawsuit accuses Salesforce of infringing patents related to database software reprogramming technology. The company argues that the judge’s dismissal was “improper and unjustified” and is seeking reinstatement of the case, arguing…

Read More

Federal Appeals Court Upholds Invalidation of USAA’s Mobile Check Deposit Patents in PNC Bank Case

The U.S. Court of Appeals for the Federal Circuit recently decided not to revisit panel decisions that overturned two significant patent infringement verdicts against PNC Bank, totaling nearly $223 million. These verdicts stemmed from claims by the United Services Automobile Association (USAA) regarding its mobile check deposit patents. The appeals court, however, invalidated the patents,…

Read More

Federal Circuit Decisions Highlight Risks of Modifying Patent Claims During Prosecution

In recent decisions, the Federal Circuit underscored the potential pitfalls associated with altering patent claims during prosecution, highlighting the intricate balance patent practitioners must maintain. These rulings emphasize the enduring principle that modifications to claims can jeopardize the enforceability of the resulting patent, as originally reported in Law360. The first case involved a technology firm…

Read More

Emergent Shift: The Rise of Patent Agents and the Future of Intellectual Property Legal Services

The landscape of patent practitioners in the United States is undergoing a notable transformation. Recent trends indicate a dwindling number of attorneys pursuing the patent bar exam, while patent agents are stepping up to fill the gap. This shift is reshaping the workforce within the intellectual property sector, signaling changing dynamics in how innovations are…

Read More

Delaware Court Rules Against Jazz Pharmaceuticals in Antitrust Narcolepsy Drug Case

The ongoing legal battle involving Jazz Pharmaceuticals has taken another turn as a Delaware federal judge ruled that the company cannot evade antitrust claims regarding its narcolepsy drug distribution method. The case centers on allegations that Jazz improperly listed its patent in the U.S. Food and Drug Administration’s Orange Book, potentially limiting competition for its…

Read More

Delaware Court Set to Rule on Sirius XM and Fraunhofer Patent Dispute Amid Allegations of Licensing Imbalance

A Delaware federal judge has scheduled a bench trial to examine whether Sirius XM Radio Inc. (SXM) relied on the Fraunhofer-Gesellschaft’s five-year delay in asserting patent claims related to satellite radio technology when making business decisions concerning that technology. This decision follows a June 9, 2025, ruling by the U.S. Court of Appeals for the…

Read More

Federal Circuit’s Decision on Wig Grip Patent Sparks Focus on Patent Language Interpretation

The Federal Circuit recently upheld a lower court’s decision in a case involving a patent for a wig grip apparatus. The court declined to revive the patent owner’s infringement lawsuit against a California-based hair replacement service. The court’s decision hinged on its agreement with the lower court’s interpretation of a pivotal phrase within the patent,…

Read More

Dickinson Wright Strengthens IP Team with Strategic Hire from PayPal to Boost Tech Sector Expertise

Dickinson Wright has made a significant addition to its intellectual property team by bringing on board a seasoned expert from PayPal. This move underscores the strategic emphasis the law firm is placing on strengthening its IP capabilities, particularly in the technology sector which is rapidly evolving with emerging innovations. The new addition to Dickinson Wright,…

Read More

Dickinson Wright Enhances IP Expertise with Strategic Hire from PayPal in Austin Office Expansion

Dickinson Wright PLLC has strategically enhanced its intellectual property capabilities by bringing in a seasoned expert from PayPal to its Austin office. The newest addition, who joins as of counsel, is expected to significantly bolster the firm’s offerings in the ever-evolving landscape of IP law. Before transitioning to Dickinson Wright, the new counsel dedicated nearly…

Read More

“Trump-Era Reforms at Patent Trial and Appeal Board Aim to Restore Balance in Patent Disputes”

The Patent Trial and Appeal Board (PTAB) underwent significant changes during the Trump administration, aimed at rebalancing its enforcement procedures to align with its foundational goals. This shift focused on restoring the PTAB’s original intent of offering a more balanced forum for patent disputes. According to Bloomberg Law, these changes were driven by concerns that…

Read More

Delaware Court Ruling Allows Avadel to Seek FDA Approval, Shaping Competitive Landscape in Sleep Disorder Treatments

Jazz Pharmaceuticals Inc. faced a legal setback as a Delaware federal judge ruled that the company cannot prevent Avadel CNS Pharmaceuticals LLC from pursuing U.S. Food and Drug Administration (FDA) approval for its sleep disorder treatment. The judge emphasized that the act of seeking FDA approval does not constitute infringing activity that warrants an injunction….

Read More

AbbVie Secures Prolonged Exclusivity for Rinvoq, Delaying Generics Until 2037

AbbVie Inc. has reached a pivotal settlement in ongoing litigation concerning its immunosuppressant drug, Rinvoq. This move effectively delays the launch of generic competitors until 2037, allowing AbbVie to maintain its market exclusivity for an extended period. The settlement resolves accusations that generic manufacturers were infringing upon multiple patents held by AbbVie, putting an end…

Read More

USPTO Director Announces Reforms to Strengthen Patent Holder Protections in Review Processes

Acting U.S. Patent and Trademark Office Director Coke Morgan Stewart has announced a series of amendments to patent review processes, underscoring a commitment to enhancing fairness for patent holders. These changes, she stated, are designed to re-align the proceedings with their original intent, thereby ensuring a balanced approach that does not unduly favor challengers over…

Read More

Federal Circuit Review of Dumbbell Patent Case Sparks Debate on Patent Eligibility Criteria

In a development that has captured the attention of patent law professionals, an exercise equipment company has called on the full Federal Circuit to scrutinize a recent panel decision. This decision revived a dumbbell patent associated with PowerBlock Holdings Inc., raising concerns about the implications for patent eligibility law. The company argues that the ruling…

Read More

USPTO Rejects Multiple PTAB Reviews, Highlighting Discretionary Complexities

Acting U.S. Patent and Trademark Office Director Coke Morgan Stewart has recently turned heads with her decision to reject 18 petitions for Patent Trial and Appeal Board (PTAB) review. These rejections, delivered on the basis of discretionary factors, signal ongoing complexities within the patent review process under her guidance. This development comes as Stewart continues…

Read More

Delaware Jury Awards $9.5 Million to Mallinckrodt in Patent Infringement Case Against Airgas Healthcare

In a significant legal decision, a Delaware federal jury awarded Mallinckrodt Pharmaceuticals nearly $9.5 million after determining that Airgas Healthcare, a company based in France, infringed patents related to an inhaled nitric oxide treatment. This verdict highlights ongoing tensions in the pharmaceutical industry concerning patent rights and innovation. The case revolves around the use of…

Read More

Novartis Appeals Delaware Court Ruling in Entresto Patent Dispute with MSN Pharmaceuticals

Novartis is actively contesting a recent decision from a Delaware federal judge, seeking intervention from the Federal Circuit to reverse a ruling which favored MSN Pharmaceuticals in a patent dispute involving Entresto, a highly profitable cardiovascular medication. The legal battle centers around whether MSN’s generic version infringes on Novartis’ patent rights, a point of significant…

Read More